日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and predictors of virological non-suppression in Thailand's rollout of dolutegravir-based first-line antiretroviral therapy: A nationwide cohort analysis

泰国推广以多替拉韦为基础的一线抗逆转录病毒疗法的疗效及病毒学抑制失败的预测因素：一项全国性队列分析

期刊:Hiv Medicine
影响因子:
doi:10.1111/hiv.70178
Hiranburana, Napon; Sophonphan, Jiratchaya; Kerr, Stephen J; Lertpiriyasuwat, Cheewanan; Noknoy, Sairat; Jirajariyavej, Supunnee; Fujitnirun, Chris; Chetchotisakd, Ploenchan; Lolekha, Rangsima; Bowonwatanuwong, Chureeratana; Ruxrungtham, Kiat; Putcharoen, Opass; Avihingsanon, Anchalee
微生物学
发表日期：2026
文献求助 收藏

Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults With Moderate Renal Function Impairment

在中度肾功能损害的HIV感染成人中，每48小时300毫克替诺福韦酯与每日一次150毫克替诺福韦酯的血浆和细胞内药代动力学比较

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/civ346
Cressey, Tim R; Avihingsanon, Anchalee; Halue, Guttiga; Leenasirimakul, Prattana; Sukrakanchana, Pra-Ornsuda; Tawon, Yardpiroon; Jaisieng, Nirattiya; Jourdain, Gonzague; Podany, Anthony T; Fletcher, Courtney V; Klinbuayaem, Virat; Bowonwatanuwong, Chureeratana
HIV
细胞生物学
炎症/感染
微生物学
发表日期：2015
文献求助 收藏

Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum

妊娠晚期和产后依非韦伦的药代动力学

期刊:Jaids-Journal of Acquired Immune Deficiency Syndromes
影响因子:2.2
doi:10.1097/QAI.0b013e31823ff052
Cressey, Tim R; Stek, Alice; Capparelli, Edmund; Bowonwatanuwong, Chureeratana; Prommas, Sinart; Sirivatanapa, Pannee; Yuthavisuthi, Prapap; Neungton, Chanon; Huo, Yanling; Smith, Elizabeth; Best, Brookie M; Mirochnick, Mark
发表日期：2012
文献求助 收藏